Literature DB >> 23568443

A 2-year follow-up of quality of life, pain, and psychosocial factors in patients with chronic prostatitis/chronic pelvic pain syndrome and their spouses.

Dean A Tripp1, J Curtis Nickel, Daniel Shoskes, Adrijana Koljuskov.   

Abstract

OBJECTIVES: There are two objectives: (1) Examine quality of life (QoL) and mood between chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients and spouses over a 2-year period; (2) Longitudinally assess CP/CPPS patient pain, disability, and pain catastrophizing over a 2-year period.
METHODS: Forty-four CP/CPPS diagnosed men and their spouses participated. Patients completed demographics, QoL, depression, anxiety, pain, disability, and catastrophizing across the study. Spouses completed QoL, depression, and anxiety. Patients/spouses were not different in education, but patients were older (49 years; SD = 9.56). The average symptom duration was 8.68 (SD = 7.61). Couples were married or common law, and majority of patients were employed. Due to attrition, approximately 21 couples provided analyzable data.
RESULTS: Patients and spouses physical QoL did not statistically differ over time from one another, and both increased over the study period. Mental QoL increased over time, but patients reported lower QoL. Patients reported more depression and anxiety, but both measures remained stable over time for spouses and patients. Finally, patient only analyses showed that disability did decrease over time from a high at 6 months, but pain and catastrophizing showed stability over the 2 years.
CONCLUSIONS: Patients reported worse mental QoL, depression, and anxiety compared to spouses, and spouses reported significant stable levels of depression and anxiety similar to patients. Further, patient catastrophizing, pain, and disability did not reduce over the 2-year assessment period. These results provide further impetus for the development and implementation of mental health strategies alongside continued medical efforts in couples suffering from CP/CPPS.

Entities:  

Mesh:

Year:  2013        PMID: 23568443     DOI: 10.1007/s00345-013-1067-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  30 in total

1.  Brief cognitive-behavioral therapy for temporomandibular disorder pain: effects on daily electronic outcome and process measures.

Authors:  Judith A Turner; Lloyd Mancl; Leslie A Aaron
Journal:  Pain       Date:  2005-10       Impact factor: 6.961

2.  Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Dean A Tripp; J Curtis Nickel; Yanlin Wang; Mark S Litwin; Mary McNaughton-Collins; J Richard Landis; Richard B Alexander; Anthony J Schaeffer; Michael P O'Leary; Michel A Pontari; Jackson E Fowler; Leroy M Nyberg; John W Kusek
Journal:  J Pain       Date:  2006-10       Impact factor: 5.820

3.  Spousal support decreases the negative impact of pain on mental quality of life in women with interstitial cystitis/painful bladder syndrome.

Authors:  Jessica V Ginting; Dean A Tripp; J Curtis Nickel; Mary Pat Fitzgerald; Robert Mayer
Journal:  BJU Int       Date:  2010-11-02       Impact factor: 5.588

Review 4.  Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis.

Authors:  Thunyarat Anothaisintawee; John Attia; J Curtis Nickel; Sangsuree Thammakraisorn; Pawin Numthavaj; Mark McEvoy; Ammarin Thakkinstian
Journal:  JAMA       Date:  2011-01-05       Impact factor: 56.272

5.  A feasibility trial of a cognitive-behavioural symptom management program for chronic pelvic pain for men with refractory chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Dean A Tripp; J Curtis Nickel; Laura Katz
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

6.  A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study.

Authors:  Kathleen Joy Propert; Mary McNaughton-Collins; Benjamin E Leiby; Michael P O'Leary; John W Kusek; Mark S Litwin
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

7.  6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training.

Authors:  Rodney U Anderson; David Wise; Timothy Sawyer; Patricia Glowe; Elaine K Orenberg
Journal:  J Urol       Date:  2011-02-22       Impact factor: 7.450

8.  Diagnosis and treatment of 409 patients with prostatitis syndromes.

Authors:  J J de la Rosette; M R Hubregtse; E J Meuleman; M V Stolk-Engelaar; F M Debruyne
Journal:  Urology       Date:  1993-04       Impact factor: 2.649

9.  Pain, perceived injustice and the persistence of post-traumatic stress symptoms during the course of rehabilitation for whiplash injuries.

Authors:  Michael J L Sullivan; Pascal Thibault; Maureen J Simmonds; Maria Milioto; André-Philippe Cantin; Ana M Velly
Journal:  Pain       Date:  2009-07-29       Impact factor: 6.961

Review 10.  The implications of depression for pain and disability in rheumatoid arthritis.

Authors:  J C Parker; G E Wright
Journal:  Arthritis Care Res       Date:  1995-12
View more
  17 in total

1.  Understanding chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Authors:  J Curtis Nickel
Journal:  World J Urol       Date:  2013-06-28       Impact factor: 4.226

2.  Physical activity and chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Ran Zhang; Andrea K Chomistek; Jordan D Dimitrakoff; Edward L Giovannucci; Walter C Willett; Bernard A Rosner; Kana Wu
Journal:  Med Sci Sports Exerc       Date:  2015-04       Impact factor: 5.411

3.  TRPV1 in experimental autoimmune prostatitis.

Authors:  Kenny Roman; Christel Hall; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Prostate       Date:  2019-10-01       Impact factor: 4.104

4.  Clinical and Psychosocial Predictors of Urological Chronic Pelvic Pain Symptom Change in 1 Year: A Prospective Study from the MAPP Research Network.

Authors:  Bruce D Naliboff; Alisa J Stephens; H Henry Lai; James W Griffith; J Quentin Clemens; Susan Lutgendorf; Larissa V Rodriguez; Craig Newcomb; Siobhan Sutcliffe; Wensheng Guo; John W Kusek; J Richard Landis
Journal:  J Urol       Date:  2017-05-18       Impact factor: 7.450

5.  Role of PAR2 in the Development of Lower Urinary Tract Dysfunction.

Authors:  Kenny Roman; Stephen F Murphy; Joseph D Done; Kevin E McKenna; Anthony J Schaeffer; Praveen Thumbikat
Journal:  J Urol       Date:  2016-02-06       Impact factor: 7.450

6.  Psychosocial mechanisms of the pain and quality of life relationship for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Authors:  Adrijana Krsmanovic; Dean A Tripp; J Curtis Nickel; Daniel A Shoskes; Michel Pontari; Mark S Litwin; Mary F McNaughton-Collins
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

7.  A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Dean A Tripp; J Curtis Nickel; Laura Katz; Adrijana Krsmanovic; Mark A Ware; Darcy Santor
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

8.  [Psychosomatic aspects of chronic pelvic pain syndrome. Psychometric results from the pilot phase of an interdisciplinary outpatient clinic].

Authors:  C A Brünahl; B Riegel; J Höink; A Kutup; E Eichelberg; B Löwe
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

9.  Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity: a case-control study.

Authors:  X Chen; C Hu; Y Peng; J Lu; N Q Yang; L Chen; G Q Zhang; L K Tang; J C Dai
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-12-15       Impact factor: 5.554

Review 10.  Management of Chronic Prostatitis (CP).

Authors:  Nadir Zaidi; Dominique Thomas; Bilal Chughtai
Journal:  Curr Urol Rep       Date:  2018-08-31       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.